Has Joshua Rozell, MD received payments from drug or device companies?

Yes. Drug and device makers reported $88,103 in general payments to Joshua Rozell, MD across 199 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Joshua Rozell, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Joshua Rozell, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Joshua Rozell, MD

Adult Reconstructive Orthopaedic Surgery · New York, NYNPI 1336587062

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $64,500 of the $88,103 with a category attached, or 73.2%. Stryker accounts for 78.0% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $43,977, 8.2 times the $5,391 reported in 2019.

$88,103in general payments, 2019–2025

Across 199 payments — averaging $442.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$69K
Medical Device Business Services, Inc.$7K
Smith+Nephew$6K
Zimmer Biomet$5K
Johnson & Johnson$502
Exactech, Inc.$333
plus $786 from 8 others

$180,497in research payments, 2019–2025

Across 13 payments — averaging $13,884 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Smith+Nephew$180K

What the payments were for

Consulting fees$64,50073%
Travel & lodging$12,30814%
Food & beverage$11,29513%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	133	$68,706
Medical Device Business Services, Inc.	7	$7,155
Smith+Nephew	28	$5,949
Zimmer Biomet	15	$4,672
Johnson & Johnson	6	$502
Exactech, Inc.	2	$333
Sanara Medtech Inc.	1	$175
Innovation Technologies Inc	1	$142
Globus Medical	1	$141
Orthalign Inc	1	$114
Encore Medical, LP	1	$103
Medtronic	1	$71
Vertex	1	$25
Solventum Corporation	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$88,103 in reported general payments places this provider in the 75th percentile of 85 adult reconstructive orthopaedic surgery providers in New York.

See all adult reconstructive orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024

$305,085

Medicare patients

419

Services billed

1,714

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diclofenac Potassium	12	$23,869
Diclofenac Sodium	68	$18,613
Lidocaine	16	$1,634
Meloxicam	163	$527
Naproxen	13	$290
Amoxicillin	346	$223
Oxycodone Hcl	79	$221
Tramadol Hcl	63	$151
Celecoxib	14	$139
Famotidine	32	$122
Cefadroxil	14	$103
Tizanidine Hcl	24	$86
Ondansetron Hcl	26	$55
Gabapentin	14	$54
Ibuprofen	20	$51

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in New York

Seth JerabekNew York$7.1M
Jose RodriguezNew York$3.4M
Friedrich BoettnerNew York$2.9M
Jonathan VigdorchikNew York$2.3M
William LongNew York$1.5M
Peter SculcoNew York$1.5M
Roshan ShahNew York$1.3M
Herbert CooperNew York$1.3M
Matthew AustinNew York$986K
Patrick MeereNew York$191K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →